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Abstract
Background: This pilot study aimed to ascertain whether the local application of ascorbic acid (AA), of T3, and of
rat (r) bone marrow mesenchymal stem cells (BMSCs), alone or in all possible combinations, promoted healing after
an Achilles tendon injury in a rat model.
Methods: An Achilles tendon defect was produced in 24 6–8-week-old male inbred Lewis rats. The animals were
then randomly divided into eight groups of three rats each. The tendon defect was filled with 50 μL of phosphate-
buffered saline (PBS) containing (1) 50 μg/mL AA (AA group), (2) 10−7 M T3 (T3 group), (3) 4 × 106 rBMSCs (rBMSC
group), (4) 50 μg/mL AA + 10−7 M T3 (AA + T3 group), (5) 4 × 106 rBMSCs + 50 μg/mL AA (rBMSC + AA group), (6)
4 × 106 rBMSCs + 10−7 M T3 (rBMSC + T3 group), (7) 4 × 10
6 rBMSCS + 50 μg/mL AA + 10−7 M T3 (rBMSC + AA + T3
group), and (8) PBS only (control group: CTRL). All treatments were administered by local injection immediately
after the tendons had been damaged; additionally, AA was injected also on the second and fourth day from the
first injection (for groups 1, 4, 5, and 7), and T3 was injected again every day for 4 days (for groups 2, 4, 6, and 7).
At 30 days from initial treatment, tendon samples were harvested, and the quality of tendon repair was evaluated
using histological and histomorphological analysis. The structure and morphology of the injured Achilles tendons
were evaluated using the modified Svensson, Soslowsky, and Cook score, and the collagen type I and III ratio was
calculated.
Results: The group treated with AA combined with T3 displayed the lowest Svensson, Soslowsky, and Cook total
score value of all tissue sections at histopathological examination, with fiber structure close to regular orientation,
normal-like tendon vasculature, and no cartilage formation. AA + T3 also showed the highest collagen I and the
lowest collagen III values compared to all other treatments including the CTRL.
Conclusion: There are potential benefits using a combination of AA and T3 to accelerate tendon healing.
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Introduction
About 3 to 5 million patients worldwide experience ten-
don injuries each year [1]. Tendon healing is slow and
often incomplete: the currently available techniques for
surgical intervention and repair are inadequate [2–5].
New procedures should be developed to produce better
outcome. In this context, tissue engineering (the combin-
ation of cells, growth factors, and carriers into functional
tissue) is a promising therapeutic option in tendon regen-
erative medicine.
Recently, cell-based, and especially stem cell-based,
strategies for tendon regeneration have attracted enor-
mous attention. Bone marrow mesenchymal stem cells
(BMSCs) have been extensively studied, displaying teno-
genic differentiation capacity [6], and are currently the
most widely used type of stem cell [7, 8], since they have
potential for improving tendon repair [6], accelerating
healing, and regenerating normal tissue. At present, how-
ever, BMSCs alone seem ineffective [9, 10], and recent
biological approaches, such as BMSCs in combination
with growth factors, and specialized delivery systems are
being explored to enhance tendon healing [11–13].
Our previous reports have shown that tendons express
thyroid hormone (TH) receptor isoforms and that T3
and T4 hormones enhance tenocyte proliferation in vitro
[14, 15]. Moreover, T3 and T4 contrast apoptosis in
healthy tenocytes in a dose- and time-dependent manner
[14, 15]. THs (especially T3) stimulate cellular prolifera-
tion and type I collagen formation, the major fibrillar
collagen in tendons. Furthermore, we have shown that,
in the presence of ascorbic acid (AA), T3 increases colla-
gen I expression, and additionally, T3 also increases
ECM protein secretion in the presence of AA and, in
particular, biglycan and COMP (cartilage oligomeric
matrix protein) expression [14, 16, 17]. Robinson et al.
recently demonstrated that biglycan is required for
mechanical proprieties in the tendon and for collagen
fiber realignment after loading [18]. COMP is known to
co-localize with collagen I [19], and a marked reduction
of COMP in tendon injury has recently been demon-
strated, suggesting the possibility of its use as a marker
for tendon injury [20]. In addition, AA on its own
triggers the proliferation of tendon-derived cells [16, 17].
AA also decreases nitric oxide synthesis (NOS) in the
same experimental condition. NOS inhibition exerts
beneficial effects on tendon regeneration and function in
a murine of Achilles tendon rupture [21]. When AA is
combined with T3, it synergistically induces an increase
in tenocyte proliferation [17].
The role of thyroid hormones in stem cell function is
still unclear and further study is required. Previous in-
vestigations have shown that the thyroid hormone T3 ex-
erts a dose-dependent effect on the chondrogenic and
osteogenic differentiation of BMSC in female rats,
promoting chondrogenic matrix formation and collagen
synthesis respectively [22, 23]. T3 treatment increases
the differentiation of BMSCs induced to cardiomyocytes
and promotes their maturation [24]. The combined
treatment of BMSC with exercise and thyroid hormones
enhances new neuronal cell generation and attenuates
apoptosis in ischemia strokes in mice [25].
There is some uncertainty as to whether BMSC trans-
plantation alone is sufficient to achieve satisfactory
outcomes in tendon repair and healing. Therefore, it is ne-
cessary to assess the effects of combining other therapies
with cell therapy to increase their therapeutic efficacy in
tendon injury. In trying to translate all these findings into
clinical practice, it would be reasonable, first of all, to
hypothesize that AA and T3 in combination would be
beneficial to human tendon healing in vivo. Moreover, no
studies have yet been performed to understand the influ-
ence of thyroid hormones on BMSCs in tendon regener-
ation, nor of thyroid hormones and BMSCs in
combination with AA.
Therefore, the present pilot study, using a rat Achilles
tendon injury model, aimed to verify the roles of rBMSC,
AA, and T3 in promoting healing after local inoculation at
the site of injury. rBMSC, AA, and T3 were used alone
and in every possible combination and compared with an
untreated control. After a period of 30 days, the efficacy of
local administration of all combinations of rBMSCs, AA,
and T3 on healing was evaluated.
Materials and methods
Ethics
All the experiments were conducted according to the
protocols of good animal experimentation under the
Italian Health Ministry approval n°513/2016-PR and in
accordance with international laws and policies (Direct-
ive 2010/63/EU of the European Parliament and of the
Council, Italian Legislative Decree 26/2014, Guide for
the Care and Use of Laboratory Animals, NIH publica-
tion 85-23, 1985).
Isolation, culture, and characterization of rat BMSCs
rBMSCs were isolated from the bone marrow of the tibia
and femur of three 6–8-week-old male inbred Lewis rats
(ENVIGO, Wyton, UK), as previously described [26]. The
bone marrow cells were seeded into a tissue culture flask
in MesenCult Basal Medium (STEMCELL Technologies,
Vancouver, Canada), supplemented with penicillin/
streptomycin (100U/mL–100 μg/mL) and 10% FBS, and
incubated at 37 °C, in a 5% CO2 atmosphere with 95%
relative humidity. Three days after seeding, floating cells
were removed, and the medium was replaced with a fresh
medium. Adherent cells were allowed to reach approxi-
mately 80% confluence (12–17 days for the first passage).
Cells were detached following treatment with StemPro
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accutase (ThermoFischer Scientific, USA) and replaced
every 6–8 days at approximately 80% confluence. Cells at
second passage (P2) were used unless otherwise stated.
When the cells in the culture flasks were nearly confluent,
the cells in the primary culture were sub-cultured and col-
lected for the study. In addition, mesenchymal stem cells
(MSCs) were tested by flow cytometry (Becton Dickinson,
Franklin Lakes, New Jersey, USA) using specific surface
markers, being negative for CD45 and positive for CD90
[27]. Debris particles were excluded from the analysis by
gating on forward and side scatter (FSC and SSC) mor-
phological parameters. Dead cells were gated out by propi-
dium iodide (0.07 μg/mL, Sigma-Aldrich, Saint Louis,
USA) staining; 10.000 viable and non-debris events in the
morphological gate were recorded for each sample. Cells
were acquired on a CytoFLEX flow Cytometer (Beckman
Dickinson, CA, USA). The analysis was performed using
CytExpert Software (Beckman Dickinson). The stem cell
characteristics of bone MSCs were routinely confirmed by
their trilineage differentiation abilities (adipocytes, osteo-
blasts, and chondrocytes) when cultured under appropri-
ate conditions in vitro before being used for experimental
procedures as previously described [27, 28]. Adipocytes
were visualized by Oil Red-O staining, osteoblasts
evidenced by alizarin red, and chondrocytes were visual-
ized with Alcian Blue. Isolated rBMSCs (P0) were cryopre-
served according to standard procedures in liquid
nitrogen in 90% fetal bovine serum + 10% DMSO and
stored in liquid nitrogen in vials until transplantation.
Animal surgery and pilot study design
Twenty-four 6–8-week-old male inbred Lewis rats
(ENVIGO) were housed under controlled conditions in
the Interdepartmental Service Centre - Station for Animal
Technology, University of Rome “Tor Vergata” (Italy),
supplied with standard diets (4RF18; Mucedola srl, Italy)
and water ad libitum. Under general anesthesia induced
using an intramuscular injection of tiletamine/zolazepam
(50mg/kg) (Zoletil 100, Virbac Italia SRL, Italy) and xyla-
zine (10mg/kg) (Rompun Bayer AG, Germany), the right
Achilles tendon was laid open by a skin incision approxi-
mately 10-mm long on the medial aspect of the right hind
limb of each rat. In each animal, an Achilles tendon defect
2mm in diameter was produced as previously described
[29] with some modifications. Briefly, the Achilles tendon
was separated from the surrounding tissue, and the med-
ial, more prominent component of the Achilles tendon,
the m. flexor digitorum superficialis, was isolated. Using a
sterile punch (diameter 2mm), which was placed around
the Achilles tendon at a distance of approximately 2mm
from the calcaneus, a full-thickness hole, 2 mm in diam-
eter, was made. The skin was closed by a continuous
suture using absorbable 4.0 absorbable monofilament su-
tures. The animals were divided into eight groups (with
three rats per group). The injured tendon was filled with
50 μL of phosphate-buffered saline (PBS), a physiological
buffer solution which contained (1) 50 μg/mL AA (AA
group), (2) 10−7M T3 (T3 group), (3) 4 × 10
6 rBMSCs
(rBMSC group), (4) 50 μg/mL AA + 10−7M T3 (AA + T3
group), (5) 4 × 106 rBMSCs + 50 μg/mL AA (rBMSC +
AA group), (6) 4 × 106 rBMSCs + 10−7M T3 (rBMSC + T3
group), (7) 4 × 106 rBMSCS + 50 μg/mL AA + 10−7M T3
(rBMSC + AA + T3 group), and (8) PBS only (control
group: CTRL). Additionally, AA was injected again on the
second and fourth day following the initial injection (for
groups 1, 4, 5, and 7), while T3 was injected again every
day for 4 days (for groups 2, 4, 6, and 7). Post-operatively,
antibiotics and analgesics were administered: 0.5 mL/kg
Baytril (Bayer AG, Germany) and 0.1mL/kg/day Rimadyl
(Veterfarma SpA, Italy). After 30 days, the animals were
anesthetized and then euthanized using CO2 in specially
designed chambers. Tendons were explanted, embedded
in optimal cutting temperature (O.C.T.) compound
medium (Sakura Finetek USA, Inc., Torrance, CA, USA),
and quickly frozen in liquid nitrogen-cooled isopentane
for sectioning at a thickness of 12 μm using a Leica (Leica
Biosystems, Wetzlar, Germany) cryostat, and then stained
with hematoxylin and eosin or Picro-Sirius red solution
for histological and histomorphometric analyses and ex-
amined under white light and polarized light microscopy,
respectively. Sections were examined independently by
two pathologists in a blinded, random order.
Histological and histomorphometric examination
For histological and histomorphometric analyses, three
sections per animal and three animals per group were
evaluated for each experimental group. Three sections of
each specimen were placed onto one slide at an approxi-
mate distance of 250 μm. Six areas were selected from
each section to cover the entire surface of the tendon
and were collected using an optical microscope (BX51,
Olympus Italia Srl, Milano, Italy) at × 10 magnification,
coupled to Aperio ScanScope (Aperio ScanScope CS,
Aperio Technologies, Leica Biosystems, USA) digital
image analysis system. A modified, semi-quantitative
score obtained by the three different scores of
Soslowsky, Svensson, and Cook’s scoring systems was
used (Table 1) [30–32]. These scores take into account
four different parameters: fiber structure, cellularity,
vascularity, and cartilage formation. Each parameter was
scored on a 4-point scale of 0–3, as follows: 0, normal;
1, slightly abnormal; 2, abnormal; and 3, markedly ab-
normal. The samples were scored according to whether
there was a significant abnormal appearance. The total
score is the sum of the values of each parameter varied
between 0 (normal tendon) and 12 (severest abnormal-
ity) [33]. For the validation study, pathologists were add-
itionally asked to make overall examinations for each
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specimen. The specimens were anonymized and random-
ized by an IRCCS Rizzoli Orthopedic Institute employee
not involved in the study. For polarization microscopy,
each section (three sections per animal, three animals per
group) were imaged using × 8 magnification. To prevent
variations in illumination and magnification, all pictures
were recorded by the same person. The sections under-
went further evaluation using computerized image analysis
software (Aperio Area Quantification FL Algorithm). Color
intensity and color amount (i.e., positively stained area)
were measured by Aperio ScanScope CS (Aperio Area
Quantification FL Algorithm, Aperio ScanScope CS Leica
Biosystems). Collagen type I and type III percentages were
calculated by these automated measurement of the
red-orange fiber area (collagen type I) and pale green fiber
area (collagen type III) from Picro-Sirius red staining [34].
Statistical analysis
Data are expressed as mean values ± standard deviation
(SD). Statistical analysis was performed using the STATA
v.14.2 software with data reported at a statistical signifi-
cance level of p < 0.05. Two-level regression models
(group-treatment = level 1 unit; rat = level 2 unit) with a
random intercept term at level 2 and the treatment
group as fixed effects, followed by adjusted Bonferroni
post hoc test, were used to compare histomorphometric
results (total score and collagen ratio). The estimates of
the fixed and random parameters were obtained by using
the restricted maximum likelihood method. The denom-
inator degrees of freedom of the null sampling distribu-
tions of test statistics for fixed effects were computed by
using the repeated method to take the bias associated
with the small sample into account.
Results
Identification of rBMSC
Once they had been isolated and cultured, the rBMSCs
were analyzed for immunophenotype by flow cytometry,
which confirmed the expression of CD90 and the lack of
CD45 (Fig. 1a). In addition, rBMSCs were functionally
characterized by differentiation into adipocytes, osteoblast,
and chondrocytes (Fig. 1b–d), displaying the typical
characteristics of MSCs [35].
Local injection of AA + T3 ameliorated tendon repair
Surgical procedures and treatments (Fig. 2) did not deter-
mine any additional accidental damage and no clinical
signs of necrosis or tissue infection. At gross examination
post mortem, scar tissue was visible at the site of the core
lesion in the center of each tendon. Macroscopically, no
differences were visible between the groups. No macro-
scopic signs of necrosis or tendon degeneration were ob-
served. The paratenon covering the tendon was of normal
thickness, as were the collagen fibers of the epitenon, and
no inflammatory infiltrate or other morphological changes
were seen. Intra-class correlation for histology scores was
excellent for inter-observer reliability (0.79–0.97 depending
on score/sub-score). The lesions could be identified clearly
on H&E staining. Histological analysis indicated incom-
plete restoration of structural integrity (Fig. 3).
Semi-quantitative histomorphometric results are re-
ported in Fig. 4. The total histological score was lower in
the AA + T3-treated group (score 1) than in all the other
group treatments (AA score 7; T3 score 5.3; rBMSC
score 4.16; rBMSC + AA score 7.16; rBMSC + T3 score
7.16; rBMSC + T3 + AA score 9.66) including the CTRL
group (score 2.3) (Fig. 4a). Specifically, in the group
treated with AA + T3, score values were lower for fiber
structure (close to regular orientation, score 0.5) than
those in the CTRL group (0.7); vasculature (vessels run
inconspicuous coursing parallel to the collagen fiber
bundles in the septa, like in a normal tendon, score 0)
than those in the CTRL group (score 0.8); and cartilage
formation (slight cartilage formation was only observed
in one section, score 0.1) than those in the CTRL group
(slight formation of cartilage in three sections for one of
the three animals, and in two sections for the second of
the three animals, score 0.5). The rBMSC group had the
same histology score as the CTRL group for cartilage
formation (slight cartilage formation was observed in
two of the three sections for the first animal and in one
section only for the other two animals in the group)
Table 1 Semi-quantitative histomorphometric scoring system as modified by Svensson, Soslowsky, and Cook
Parameter Grade 0 Grade 1 Grade 2 Grade 3
Fiber structure, Svenson
and Solowsky scores
Normal parallel
collagen fibers
Mild changes
(< 25% slightly
separated fibers)
Moderate changes
(25–50% disorganized,
separated, and
deteriorated fibers)
Marked changes
(> 50% disorganized
and hyalinized fibers)
Cellularity (aspect), Cook scores Elongated nuclei and
absence of cytosol
Oval nucleus and
absence of cytosol
Round nucleus and
little cytosol
Round nucleus and
abundant cytosol
Vascularity, Svensson
score
Few vessels, parallel
to the fiber
Slight increase
of vessels
Moderate increase
of vessels
Marked increase
of vessels
Cartilage formation No cartilage Isolated cartilage
nodules
Moderate cartilage
formation (25–50%)
Extensive cartilage
formation (> 50%)
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(Fig. 4b). The AA + T3 group total scores were significantly
lower than those of the rBMSC + T3 group (p < 0.005) and
the rBMSC + AA + T3 group (p < 0.0001). The rBMSC +
AA + T3 group scored significantly higher than the CTRL
group. Specifically, the AA + T3 group sub-scores were
lower for fiber structure in comparison with the AA group,
the rBMSC + AA group, the rBMSC + T3 group, and the
rBMSC + AA + T3 group (p < 0.005); for cellularity scores,
the AA + T3 group sub-scores were lower than for all other
groups and, most significantly, than for the rBMSC + AA
group, the rBMSC + T3 group, and the rBMSC + AA + T3
group (p < 0.005); for vascularity, the AA + T3 group
sub-scores were significantly lower than for the AA group
and the rBMSC + AA + T3 group (p < 0.005), and the AA +
Fig. 1 rBMSC characterization. An example of rBMSCs phenotype and functional analysis. a Flow cytometry analysis of MSCs for surface markers
(CD45+ isotype control, CD90+ isotype control, negative control) showed that isolated bone marrow-derived cells expressed CD90, but not the
hematopoietic marker CD45, confirming that only mesenchymal cells had been isolated (CD45−CD90+ cells population). b–d In vitro
differentiation of mesenchymal cells: the cells were incubated in lineage-specific induction media and then analyzed by histochemical and
cytological staining for b adipocytes (Oil Red-O staining), c osteoblasts (alizarin red staining), and d chondrocytes (Alcian Blue staining)
Fig. 2 Surgical procedure. a, b Under general anesthesia, the right Achilles tendon was laid open by a skin incision approximately 10-mm long
on the medial aspect of the right hind limb. c A 1-mm sterile punch was placed around the Achilles tendon at a distance of approximately 2 mm
from the calcaneal bone. d Treated area: the skin was closed by a continuous suture and each treatment locally micro-injected
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T3 group cartilage formation sub-scores were lower than all
the other group treatments (Fig. 4b). In the AA + T3 group,
the vascularity sub-score value was similar to that of a
healthy tendon (Fig. 4b), and the value was significantly
lower than that for the AA + T3 group and for the rBMSC +
AA + T3 group (p < 0.005) (Fig. 4b).
Analysis of the collagen ratio revealed that the association
AA + T3 exerted greater effect on tendon healing than all
the other treatments. Specifically, the collagen type I value
was significantly higher than in the rBMSC + AA group
and the rBMSC + AA + T3 group (p < 0.05; p < 0.01); the
AA + T3 group collagen type III value was significantly
lower than in the rBMSC + AA group and the rBMSC +
AA + T3 group (p < 0.05; p < 0.01) (Fig. 5). The collagen
type I value of the rBMSC + AA + T3 group was signifi-
cantly lower than the CTRL (p < 0.05), and the collagen
type III value was significantly higher in the rBMSC+AA
+T3 group than the CTRL group (p < 0.05) (Fig. 5).
Discussion
We wished to test the effect of local micro-injection of
AA, T3, and rBMSCs, individually and in every possible
combination, on tendon healing in damaged rat tendons.
Our investigation logically follows prior studies which
demonstrated the relevance of ascorbic acid and T3 in
combination with the biological function of tenocytes.
Novel preliminary findings demonstrate the efficacy of
ascorbic acid in combination with the T3 hormone in
improving tendon healing, confirming our previous in
vitro studies [14, 16, 17]. Histological evaluation con-
firmed better restoration of normal tendon architecture
with an optimal alignment of tendon fibers and blood
vessels, although the continued presence of high cellu-
larity suggests that the regenerative process was not
complete. Furthermore, in the tendons treated with AA
+ T3, the analysis of the collagen ratios demonstrated a
higher expression of collagen type I, and lower expres-
sion of collagen type III, than in all the other groups,
including the CTRL group. Comparison of the AA + T3
treatment with the AA alone, and the T3 alone, showed
that the co-administration of AA and T3 yielded greater
beneficial effects than the administration of either separ-
ately. The histological score values and the collagen ra-
tios were worse for AA alone, and for T3 alone, than for
the CTRL group, although they were better than for the
rBMSC + AA group, the rBMSC + T3 group, and the
rBMSC + AA + T3 group. This was not the case for the
histological score value of the rBMSC group. The heal-
ing process of an injured tendon passes through three
main phases, featuring distinctive cellular and molecular
cascades: (i) inflammatory; (ii) reparative (proliferation),
characterized by cellularity and matrix production,
Fig. 3 Histological analysis of tendon healing at 30 days from injury/start of treatment. a The injured Achilles tendons were then stained with
H&E for each type of treatment, and the quality of tendon repair was evaluated based on properties displayed. [CF (cartilage formation), V
(vessel); SCF (slight cartilage f)] (× 500). b longitudinal sections of the right hind limb rat Achilles tendons stained by Picro-Sirius red staining (PSR):
(magnification × 4, scale bar = 500 μm). The thicker, mature collagen fibers appear red-orange (type I collagen); the thinner collagen fibers appear
pale green (type III collagen)
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which is mostly collagen type III; and (iii) remodeling
(consolidation and maturation), replacing collagen type
III with collagen type I and fiber organization [36].
Taken together, the results indicate that ascorbic acid
acts in synergy with T3 to accelerate tendon healing.
Our results agree not only with our own previous data,
but also with other studies [3, 37]. Ascorbic acid stimu-
lates a wide range of tissue functions; it contributes not
only to increased collagen synthesis and cross-linking,
but also plays key roles in stem cell function, such as in
the differentiation of mesenchymal stem cells into
tenocytes [37, 38]. Supplementation with ascorbic acid
also enhances tendon healing in mouse models [39].
Moreover, thyroid hormones are major determinants of
tissue function, playing well-defined roles in cell signal-
ing. The role of thyroid hormones in tenocyte physiology
is a novel area of study in this field [14, 15, 40, 41].
Moreover, THs regulate the function of stem cells, con-
trolling self-renewal, proliferation, and differentiation. In
vivo studies suggest high intracellular level requirement
of T3 to support normal myogenesis and muscle repair
after cardiotoxin injury [42]. All the animals in the
Fig. 4 Stacked histograms of the semi-quantitative histomorphometric score for treated and untreated control groups. a Total score for healthy
tendon score, including cartilage formation, vascularity, cell aspect, and fiber structure scores (mean, n = 3). b Detailed sub-scores. One-way
ANOVA test and adjusted Bonferroni (two-way) post hoc test
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groups treated with rBMSC healed less well than all the
other groups, including the CTRL group, when analyzed
histopathologically and histomorphologically. The group
which received rBMSC only showed better results than
the rBMSC + AA group, the rBMSC + T3 group, and
the rBMSC + AA + T3 group. At present, the use of
mesenchymal stem cells in tendon healing is still the
subject of controversy, debate, and study. Indeed, only
three BMSC-based therapies have shown favorable out-
comes in rat studies with improved histological and bio-
mechanical tendon properties [43]. However, in
accordance with our investigation, several other studies
were not able to demonstrate beneficial effects of BMSC
on tendon healing. Furthermore, no difference in colla-
gen production or in extracellular matrix organization
has been demonstrated. The source of stem cells for im-
plantation is still under debate. In the present investiga-
tion, the cells used were derived from the bone marrow,
but recent developments suggest that stem cells derived
from the tendons themselves show the greatest promise
to improve healing [44]. Moreover, it should be under-
lined that growth factors in combination with the cells
have recently been shown to require controlled spatio-
temporal delivery to the repair site to improve tendon
healing [12, 44]. Consequently, greater enhancement of
tendon healing could be obtained by specialized delivery
approaches, for example, by tissue engineering using a
variety of scaffolds [12, 44]. The exact mechanisms of
tendon healing and the precise roles that different cell
types play in the process are, as yet, not clear, and fur-
ther studies are necessary to develop a range of suitable
techniques involving stem cells to favor and hasten
tendon regeneration and repair [45].
Our results do not confirm the findings of previous
studies regarding the use of AA in combination with
MSCs [39, 46]. This is likely because of the different
methodology and different model used and the different
source of the stem cells. Kang et al. used AA to stimu-
late MSCs before transplantation in a mouse tendonitis
model, using adipose-derived cells [39]. Durant et al.
used an in vitro model employing tendon-derived stem
cells, which may have had some bearing on the results
obtained [46]. T3 has not been used in previous in vivo
studies. Hence, no direct comparisons can be made yet,
and therefore, further work is required to understand
the precise mechanisms involved and the full extent of
possible benefits in any clinical applications which may
be developed to improve, enhance, and/or accelerate
tendon healing.
Conclusions
There are several limitations to the present pilot study.
First, owing to our focus on histological and histomorpho-
metric examination of repair, only one middle-term evalu-
ation point was used. It remains inconclusive whether or
not the effects of using BMSCs, AA, and T3 alone, and in
every possible treatment combination, lead to short- and
long-term structural and functional benefits to tendon
healing. Secondly, the effectiveness of AA combined with
T3 in improving strength and stiffness following the repair
of rat tendons requires further analysis.
Despite these considerations, the present study would
appear to [14–17] confirm the hypothesis that AA used
in combination with T3 improves tendon healing in vivo,
based upon the best histological score evaluation
achieved and on collagen I and III ratio measurement.
Fig. 5 Histograms of type I and type III collagen content, expressed in percentages, for treated and untreated control groups (mean ± SD, n = 3).
One-way ANOVA test and adjusted Bonferroni (two-way) post hoc test
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In the present investigation, for the first time, T3 has been
utilized for tendon healing in an animal model, and that,
apart from our previous in vitro study, no other studies
have been made that investigate the activity of T3 in ten-
dons. For this reason, our experimental model combining
AA with T3 and with BMSCs is unique to date. Our results
must stimulate two further areas of investigation—on the
one hand, into the comprehension of the underlying mech-
anistic processes of T3 in a tendon environment and the
associated complex interaction between T3, AA, and
BMSCs; secondly, our data suggest that AA in combin-
ation with T3 could be used to develop possible cell-free
therapy for improved tendon healing. Furthermore, it will
be important to identify optimum delivery methods and
doses of AA + T3 to improve tendon healing and avoid
potential toxicity and, ultimately, to translate this approach
into clinical applications in humans.
Abbreviations
AA: Ascorbic acid; BMSCs: Bone marrow mesenchymal stem cells; COMP: Cartilage
oligomeric matrix protein; CTRL: Control group; ECM: Extracellular matrix;
FSC: Forward scatter; H&E: Hematoxylin and eosin; r: Rat; SD: Standard deviation;
SSC: Side scatter; TH: Thyroid hormones
Acknowledgments
The authors thank Dr. C. Gargioli, from the Department of Biology, University
of Rome “Tor Vergata”, Rome, Italy for his invaluable contribution to the
discussion.
Funding
This study was financed by the PCFF Foundation, Pescara, Italy.
Availability of data and materials
The dataset supporting the conclusions of this article is included within
the article.
Authors’ contributions
CG and CALP carried out the isolation, culture, and functional characterization of
rat BMSCs. MF, SB, and FV performed the histological and histomorphometric
examinations. LC performed the data analysis. MG performed the histological flow
cytometry. RB, RC, and MM operated on the experimental animals. FO operated on
the animal surgery and made substantial contributions to the design of the study,
data acquisition, and analysis. NM made substantial contributions to the conception
of this project, critically analyzed and interpreted the data, and revised the
manuscript for intellectual content. ACB conceived the study, made substantial
contributions to its design and coordination, data acquisition, analysis, and
interpretation, and drafted the manuscript. All authors read and approved the final
manuscript.
Ethics approval and consent to participate
Ethical approval was obtained from Italian Health Ministry approval n°513/
2016-PR.
Not applicable. Consent was not necessary for our study.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Author details
1Department of Orthopaedics and Traumatology, Surgery and Dentistry,
Azienda Ospedaliera San Giovanni di Dio e Ruggi d’Aragona, University of
Salerno School of Medicine, Salerno, Italy. 2Centre for Sports and Exercise
Medicine, Queen Mary University of London, Barts and the London School of
Medicine and Dentistry, Mile End Hospital, London, UK. 3Institute of Science
and Technology in Medicine, Keele University Medical School, Stoke on
Trent, UK. 4U.O.C. of Immunohaematology and Transfusion Medicine,
Laboratory of Stem Cells, Spirito Santo Hospital, Pescara, Italy. 5Laboratory of
Preclinical and Surgical Studies, Research Innovation and Technology
Department (RIT), IRCCS Rizzoli Orthopedic Institute, Via di Barbiano 1/10,
40136 Bologna, Italy. 6Dipartimento di Sanità Pubblica e Medicina di
Comunità, Sezione di Epidemiologia e Statistica Medica, Università di Verona,
37134 Verona, Italy. 7Department of Medical, Oral and Biotechnological
Sciences, University “G. d’Annunzio” Chieti-Pescara, Chieti, Italy.
8Interdepartmental Service Centre - Station for Animal Technology, University
of Rome “Tor Vergata”, Rome, Italy. 9Department of Biology, University of
Rome “Tor Vergata”, Rome, Italy.
Received: 10 June 2018 Accepted: 7 February 2019
References
1. Sharma P, Maffulli N. Biology of tendon injury: healing, modeling and
remodeling. J Musculoskelet Neuronal Interact. 2006;6(2):181–90.
2. Woo SL, Hildebrand K, Watanabe N, Fenwick JA, Papageorgiou CD, Wang
JH. Tissue engineering of ligament and tendon healing. Clin Orthop Relat
Res. 1999;(367 Suppl):S312–23.
3. Maffulli N, Wong J, Almekinders LC. Types and epidemiology of
tendinopathy. Clin Sports Med. 2003;22(4):675–92.
4. Goh JC, Ouyang HW, Teoh SH, Chan CK, Lee EH. Tissue-engineering
approach to the repair and regeneration of tendons and ligaments. Tissue
Eng. 2003;9(Suppl 1):S31–44. https://doi.org/10.1089/10763270360696969.
5. Gaspar D, Spanoudes K, Holladay C, Pandit A, Zeugolis D. Progress in cell-
based therapies for tendon repair. Adv Drug Deliv Rev. 2015;84:240–56.
https://doi.org/10.1016/j.addr.2014.11.023.
6. Dai L, Hu X, Zhang X, Zhu J, Zhang J, Fu X, et al. Different tenogenic
differentiation capacities of different mesenchymal stem cells in the
presence of BMP-12. J Transl Med. 2015;13:200. https://doi.org/10.1186/
s12967-015-0560-7.
7. Yin Z, Guo J, Wu TY, Chen X, Xu LL, Lin SE, et al. Stepwise differentiation of
mesenchymal stem cells augments tendon-like tissue formation and defect
repair in vivo. Stem Cells Transl Med. 2016;5(8):1106–16. https://doi.org/10.
5966/sctm.2015-0215.
8. Raggi C, Berardi AC. Mesenchymal stem cells, aging and regenerative
medicine. Muscles Ligaments Tendons J. 2012;2(3):239–42.
9. Khan MR, Dudhia J, David FH, De Godoy R, Mehra V, Hughes G, et al.
Bone marrow mesenchymal stem cells do not enhance intra-synovial
tendon healing despite engraftment and homing to niches within the
synovium. Stem Cell Res Ther. 2018;9(1):169. https://doi.org/10.1186/
s13287-018-0900-7m.
10. Gulotta LV, Kovacevic D, Ehteshami JR, Dagher E, Packer JD, Rodeo SA.
Application of bone marrow-derived mesenchymal stem cells in a rotator
cuff repair model. Am J Sports Med. 2009;37(11):2126–33. https://doi.org/10.
1177/0363546509339582.
11. Govoni M, Berardi AC, Muscari C, Campardelli R, Bonafè F, Guarnieri C, et al.
An engineered multiphase three-dimensional microenvironment to ensure
the controlled delivery of cyclic strain and human growth differentiation
factor 5 for the tenogenic commitment of human bone marrow
mesenchymal stem cells. Tissue Eng Part A. 2017;23(15–16):811–22. https://
doi.org/10.1089/ten.TEA.2016.0407.
12. Yan Z, Yin H, Nerlich M, Pfeifer CG, Docheva D. Boosting tendon repair:
interplay of cells, growth factors and scaffold-free and gel-based carriers. J
Exp Orthop. 2018;5(1):1. https://doi.org/10.1186/s40634-017-0117-1.
13. Chaudhury S. Mesenchymal stem cell applications to tendon healing.
Muscles Ligaments Tendons J. 2012;2(3):222–9.
14. Oliva F, Berardi AC, Misiti S, Verga Falzacappa C, Iacone A, Maffulli N. Thyroid
hormones enhance growth and counteract apoptosis in human tenocytes
isolated from rotator cuff tendons. Cell Death Dis. 2013;4:e705. https://doi.
org/10.1038/cddis.2013.229.
15. Oliva F, Piccirilli E, Berardi AC, Tarantino U, Maffulli N. Influence of thyroid
hormones on tendon homeostasis. Adv Exp Med Biol. 2016;920:133–8.
https://doi.org/10.1007/978-3-319-33943-6_12.
16. Berardi AC, Oliva F, Berardocco M, la Rovere M, Accorsi P, Maffulli N. Thyroid
hormones increase collagen I and cartilage oligomeric matrix protein
Oliva et al. Journal of Orthopaedic Surgery and Research           (2019) 14:54 Page 9 of 10
(COMP) expression in vitro human tenocytes. Muscles Ligaments Tendons J.
2014;4(3):285–91.
17. di Giacomo V, Berardocco M, Gallorini M, Oliva F, Colosimo A, Cataldi A, et
al. Combined supplementation of ascorbic acid and thyroid hormone T3
affects tenocyte proliferation. The effect of ascorbic acid in the production
of nitric oxide. Muscles Ligaments Tendons J. 2017;7(1):11–8. https://doi.org/
10.11138/mltj/2017.7.1.011.
18. Robinson KA, Sun M, Barnum CE, Weiss SN, Huegel J, Shetye SS, et al. Decorin
and biglycan are necessary for maintaining collagen fibril structure, fiber
realignment, and mechanical properties of mature tendons. Matrix Biol. 2017;
64:81–93. https://doi.org/10.1016/j.matbio.2017.08.004.
19. Södersten F, Hultenby K, Heinegård D, Johnston C, Ekman S.
Immunolocalization of collagens (I and III) and cartilage oligomeric matrix
protein in the normal and injured equine superficial digital flexor tendon.
Connect Tissue Res. 2013;54(1):62–9. https://doi.org/10.3109/03008207.2012.
734879.
20. Hakimi O, Ternette N, Murphy R, Kessler BM, Carr A. A quantitative label-free
analysis of the extracellular proteome of human supraspinatus tendon
reveals damage to the pericellular and elastic fibre niches in torn and aged
tissue. PLoS One. 2017;12(5):e0177656. https://doi.org/10.1371/journal.pone.
0177656 eCollection 2017.
21. Moraes SA, Oliveira KR, Crespo-López ME, Picanço-Diniz DL, Herculano AM.
Local NO synthase inhibition produces histological and functional recovery
in Achilles tendon of rats after tenotomy: tendon repair and local NOS
inhibition. Cell Tissue Res. 2013;353(3):457–63. https://doi.org/10.1007/
s00441-013-1662-2.
22. Assis HA, Elert NC, Azevedo ALBP, Braga IS, Serakides R, de Melo ON, et
al. Dose-dependent effect of triiodothyronine on the chondrogenic
differentiation of mesenchymal stem cells from the bone marrow of
female rats. J Pharm Pharmacol. 2018;70(1):89–100. https://doi.org/10.
1111/jphp.12842.
23. Boeloni JN, Ocarino NM, Melo AB, Silva JF, Castanheira P, Goes AM, et al.
Dose-dependent effects of triiodothyronine on the osteogenic
differentiation of rat bone marrow mesenchymal stem cells. Horm Res.
2009;72(2):88–97. https://doi.org/10.1159/000232161.
24. Shi ST, Wu XX, Hao W, Wang X, Miao HT, Zhen L, et al. Triiodo-L-thyronine
promotes the maturation of cardiomyocytes derived from rat bone marrow
mesenchymal stem cells. J Cardiovasc Pharmacol. 2016;67(5):388–93. https://
doi.org/10.1097/FJC.0000000000000363.
25. Akhoundzadeh K, Vakili A, Sameni HR, Vafaei AA, Rashidy-Pour A, Safari M, et
al. Effects of the combined treatment of bone marrow stromal cells with
mild exercise and thyroid hormone on brain damage and apoptosis in a
mouse focal cerebral ischemia model. Metab Brain Dis. 2017;32(4):1267–77.
https://doi.org/10.1007/s11011-017-0034-0.
26. Lennon DP, Haynesworth SE, Young RG, Dennis JE, Caplan AI. A chemically
defined medium supports in vitro proliferation and maintains the
osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp
Cell Res. 1995;219(1):211–22. https://doi.org/10.1006/excr.1995.1221.
27. Zhang T, Lee YW, Rui YF, Cheng TY, Jiang XH, Li G. Bone marrow-derived
mesenchymal stem cells promote growth and angiogenesis of breast and
prostate tumors. Stem Cell Res Ther. 2013;4(3):70. https://doi.org/10.1186/scrt221.
28. Chen X, McClurg A, Zhou GQ, McCaigue M, Armstrong MA, Li G.
Chondrogenic differentiation alters the immunosuppressive property of
bone marrow-derived mesenchymal stem cells, and the effect is partially
due to the upregulated expression of B7 molecules. Stem Cells. 2007;25(2):
364–70. https://doi.org/10.1634/stemcells.2006-0268.
29. Schramme M, Hunter S, Campbell N, Blikslager A, Smith R. A surgical
tendonitis model in horses: technique, clinical, ultrasonographic and
histological characterisation. Vet Comp Orthop Traumatol. 2010;23(4):231–9.
https://doi.org/10.3415/VCOT-09-10-0106.
30. Soslowsky LJ, Carpenter JE, DeBano CM, Banerji I, Moalli MR. Development
and use of an animal model for investigations on rotator cuff disease. J
Shoulder Elb Surg. 1996;5(5):383–92.
31. Cook JL, Feller JA, Bonar SF, Khan KM. Abnormal tenocyte morphology is
more prevalent than collagen disruption in asymptomatic athletes’ patellar
tendons. J Orthop Res. 2004;22(2):334–8. https://doi.org/10.1016/j.orthres.
2003.08.005.
32. Svensson M, Kartus J, Christensen LR, Movin T, Papadogiannakis N, Karlsson
J. A long-term serial histological evaluation of the patellar tendon in
humans after harvesting its central third. Knee Surg Sports Traumatol
Arthrosc. 2005;13(5):398–404. https://doi.org/10.1007/s00167-004-0590-9.
33. Sandri M, Filardo G, Kon E, Panseri S, Montesi M, Iafisco M, et al. Fabrication
and pilot in vivo study of a collagen-BDDGE-elastin core-shell scaffold for
tendon regeneration. Front Bioeng Biotechnol. 2016;4:52. https://doi.org/10.
3389/fbioe.2016.00052.
34. Majewski M, Ochsner PE, Liu F, Flückiger R, Evans CH. Accelerated healing of
the rat Achilles tendon in response to autologous conditioned serum. Am J
Sports Med. 2009;37(11):2117–25. https://doi.org/10.1177/
0363546509348047.
35. Javazon EH, Colter DC, Schwarz EJ, Prockop DJ. Rat marrow stromal cells are
more sensitive to plating density and expand more rapidly from single-cell-
derived colonies than human marrow stromal cells. Stem Cells. 2001;19(3):
219–25. https://doi.org/10.1634/stemcells.19-3-219.
36. Docheva D, Müller SA, Majewski M, Evans CH. Biologics for tendon
repair. Adv Drug Deliv Rev. 2015;84:222–39. https://doi.org/10.1016/j.
addr.2014.11.015.
37. D’Aniello C, Cermola F, Patriarca EJ, Minchiotti G. Vitamin C in stem cell
biology: impact on extracellular matrix homeostasis and epigenetics. Stem
Cells Int. 2017:8936156. https://doi.org/10.1155/2017/8936156.
38. Shaw G, Lee-Barthel A, Ross ML, Wang B, Baar K. Vitamin C-enriched gelatin
supplementation before intermittent activity augments collagen synthesis.
Am J Clin Nutr. 2017;105(1):136–43. https://doi.org/10.3945/ajcn.116.138594.
39. Kang KK, Lee EJ, Kim YD, Chung MJ, Kim JY, Kim SY, et al. Vitamin C
improves therapeutic effects of adipose-derived stem cell transplantation in
mouse tendonitis model. In Vivo. 2017;31(3):343–8. https://doi.org/10.21873/
invivo.11065.
40. Oliva F, Berardi AC, Misiti S, Maffulli N. Thyroid hormones and tendon:
current views and future perspectives. Muscles Ligaments Tendons J. 2013;
3(3):201.
41. Oliva F, Piccirilli E, Berardi AC, Frizziero A, Tarantino U, Maffulli N. Hormones
and tendinopathies: the current evidence. Br Med Bull. 2016;117(1):39–58.
https://doi.org/10.1093/bmb/ldv054.
42. Salvatore D. Deiodinases and stem cells: an intimate relationship. J
Endocrinol Investig. 2018;41(1):59–66. https://doi.org/10.1007/s40618-
017-0737-4.
43. Chong AK, Ang AD, Goh JC, Hui JH, Lim AY, Lee EH, et al. Bone marrow-
derived mesenchymal stem cells influence early tendon-healing in a rabbit
Achilles tendon model. J Bone Joint Surg Am. 2007;89(1):74–81. https://doi.
org/10.2106/JBJS.E.01396.
44. Lui PP, Wong OT, Lee YW. Transplantation of tendon-derived stem cells
pre-treated with connective tissue growth factor and ascorbic acid in
vitro promoted better tendon repair in a patellar tendon window injury
rat model. Cytotherapy. 2016;18(1):99–112. https://doi.org/10.1016/j.jcyt.
2015.10.005.
45. Schneider M, Angele P, Järvinen TAH, Docheva D. Rescue plan for
Achilles: therapeutics steering the fate and functions of stem cells in
tendon wound healing. Adv Drug Deliv Rev. 2017. https://doi.org/10.
1016/j.addr.2017.12.016.
46. Durant TJ, Dyment N, McCarthy MB, Cote MP, Arciero RA, Mazzocca AD, et
al. Mesenchymal stem cell response to growth factor treatment and low
oxygen tension in 3-dimensional construct environment. Muscles Ligaments
Tendons J. 2014;4(1):46–51.
Oliva et al. Journal of Orthopaedic Surgery and Research           (2019) 14:54 Page 10 of 10
